These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 38542088)

  • 1. Beyond Quadruple Therapy and Current Therapeutic Strategies in Heart Failure with Reduced Ejection Fraction: Medical Therapies with Potential to Become Part of the Therapeutic Armamentarium.
    Kourek C; Briasoulis A; Papamichail A; Xanthopoulos A; Tsougos E; Farmakis D; Paraskevaidis I
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart Failure With Reduced Ejection Fraction: A Review.
    Murphy SP; Ibrahim NE; Januzzi JL
    JAMA; 2020 Aug; 324(5):488-504. PubMed ID: 32749493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of Hydralazine and Isosorbide-Dinitrate in the Treatment of Patients with Heart Failure with Reduced Ejection Fraction.
    Nyolczas N; Dékány M; Muk B; Szabó B
    Adv Exp Med Biol; 2018; 1067():31-45. PubMed ID: 29086392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond quadruple therapy: the potential roles for ivabradine, vericiguat, and omecamtiv mecarbil in the therapeutic armamentarium.
    Shoji S; Mentz RJ
    Heart Fail Rev; 2024 Sep; 29(5):949-955. PubMed ID: 38951303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient Eligibility for Established and Novel Guideline-Directed Medical Therapies After Acute Heart Failure Hospitalization.
    Moghaddam N; Hawkins NM; McKelvie R; Poon S; Joncas SX; MacFadyen J; Honos G; Wang J; Rojas-Fernandez C; Kok M; Sidhu V; Zieroth S; Virani SA
    JACC Heart Fail; 2023 May; 11(5):596-606. PubMed ID: 36732099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical Management of Patients With Heart Failure and Reduced Ejection Fraction.
    Greenberg B
    Korean Circ J; 2022 Mar; 52(3):173-197. PubMed ID: 35257531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction.
    Tromp J; Ouwerkerk W; van Veldhuisen DJ; Hillege HL; Richards AM; van der Meer P; Anand IS; Lam CSP; Voors AA
    JACC Heart Fail; 2022 Feb; 10(2):73-84. PubMed ID: 34895860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal effects of guideline-directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology.
    Mullens W; Martens P; Testani JM; Tang WHW; Skouri H; Verbrugge FH; Fudim M; Iacoviello M; Franke J; Flammer AJ; Palazzuoli A; Barragan PM; Thum T; Marcos MC; Miró Ò; Rossignol P; Metra M; Lassus J; Orso F; Jankowska EA; Chioncel O; Milicic D; Hill L; Seferovic P; Rosano G; Coats A; Damman K
    Eur J Heart Fail; 2022 Apr; 24(4):603-619. PubMed ID: 35239201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Heart Failure With Reduced Ejection Fraction.
    Rashid AM; Khan MS; Fudim M; DeWald TA; DeVore A; Butler J
    Curr Probl Cardiol; 2023 May; 48(5):101596. PubMed ID: 36681212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials.
    Vaduganathan M; Claggett BL; Jhund PS; Cunningham JW; Pedro Ferreira J; Zannad F; Packer M; Fonarow GC; McMurray JJV; Solomon SD
    Lancet; 2020 Jul; 396(10244):121-128. PubMed ID: 32446323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vericiguat, organic nitrates, and heart failure in African Americans.
    Ilonze OJ; Guglin M
    Int J Cardiol; 2021 Sep; 338():136-137. PubMed ID: 34157357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dapagliflozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction.
    Blair HA
    Am J Cardiovasc Drugs; 2021 Nov; 21(6):701-710. PubMed ID: 34651263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.
    Ghali JK; Tam SW; Ferdinand KC; Lindenfeld J; Sabolinski ML; Taylor AL; Worcel M; Curry CL; Cohn JN;
    Am J Cardiovasc Drugs; 2007; 7(5):373-80. PubMed ID: 18041162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal Pharmacologic Treatment of Heart Failure With Preserved and Mildly Reduced Ejection Fraction: A Meta-analysis.
    Xiang B; Zhang R; Wu X; Zhou X
    JAMA Netw Open; 2022 Sep; 5(9):e2231963. PubMed ID: 36125813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of Comprehensive Quadruple Therapy for Heart Failure With Reduced Ejection Fraction.
    Dixit NM; Parikh NU; Ziaeian B; Jackson N; Fonarow GC
    JACC Heart Fail; 2023 May; 11(5):541-551. PubMed ID: 36892492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments.
    Naegele M; Flammer AJ; Enseleit F; Ruschitzka F
    Swiss Med Wkly; 2016; 146():w14295. PubMed ID: 26968014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 'diamond' approach to personalized drug treatment of heart failure with reduced ejection fraction.
    Gan H; Tang H; Huang Y; Wang D; Pu P; Zuo Z
    Rev Cardiovasc Med; 2021 Sep; 22(3):573-584. PubMed ID: 34565061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omecamtiv Mecarbil: A Novel Mechanistic and Therapeutic Approach to Chronic Heart Failure Management.
    Patel PH; Nguyen M; Rodriguez R; Surani S; Udeani G
    Cureus; 2021 Jan; 13(1):e12419. PubMed ID: 33542867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate in African-American Patients With Heart Failure.
    Ziaeian B; Fonarow GC; Heidenreich PA
    JACC Heart Fail; 2017 Sep; 5(9):632-639. PubMed ID: 28711446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium-Glucose Cotransporter 2 Inhibitors First Strategy Improve Decongestion in Patients with Symptomatic Heart Failure and Reduced Ejection Fraction When Compared to Angiotensin Receptor Neprilysin Inhibitor First Strategy.
    Lee WC; Chang WT; Hong CS; Liao CT; Huang PS; Huang SC; Lin CH; Chiang CY; Chen ZC; Shih JY
    Front Biosci (Landmark Ed); 2023 Apr; 28(4):81. PubMed ID: 37114551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.